Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway

Yang,Ning; Zhao,Yuying; Wang,Zhipeng; Liu,Yu; Zhang,Yanqiao

doi:10.3892/mmr.2016.6081

Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway

Authors:
- Ning Yang
- Yuying Zhao
- Zhipeng Wang
- Yu Liu
- Yanqiao Zhang
View Affiliations

Affiliations: Department of Oncology, The Affiliated Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Clinical and Laboratory Medicine, The Affiliated Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Gastrointestinal Oncology, The Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, P.R. China
Published online on: December 28, 2016 https://doi.org/10.3892/mmr.2016.6081
Pages: 929-935

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Scutellarin is a flavonoid isolated from a medicinal herb Scutellaria barbata D. Don and exerts therapeutic effects on cardiovascular diseases. However, it remains unclear whether Scutellarin exhibits anti‑tumor actions on human colon cancer. The current study aimed to investigate whether Scutellarin produces antiproliferative and pro‑apoptotic effects on HCT‑116 human colon cancer cells and to elucidate the mechanisms involved. Human colon cancer cells were exposed to different concentrations of Scutellarin, and cellular growth and apoptosis were evaluated by MTT assay, terminal deoxynucleotidyl transferase‑mediated dUTP nick end labeling (TUNEL) staining, western blot analysis and other assays. A cell viability assay demonstrated that Scutellarin treatment reduced the viability of HCT‑116 cells in a dose‑ and time‑dependent manner. TUNEL staining demonstrated that Scutellarin also induced apoptotic changes in HCT‑116 cells. The expression level of the anti‑apoptotic protein, Bcl‑2 apoptosis regulator (Bcl‑2), was reduced by Scutellarin in HCT‑116 cells, whereas the expression Bcl‑2 associated X apoptosis regulator (Bax) and the activation of caspase‑3 protein were increased by Scutellarin treatment. Further investigation revealed that Scutellarin significantly increased the phosphorylation of p53 protein in HCT‑116 cells. Additionally, suppression of p53 using a specific inhibitor, pifithrin‑α, abrogated the pro‑apoptotic effects of Scutellarin in HCT‑116 cells. Collectively, Scutellarin reduced the viability and induced apoptosis of human colon carcinoma cells, potentially by regulating p53 and Bcl‑2/Bax expression. These data suggested that Scutellarin may be useful as a promising anti‑tumor drug for treating colon cancer.

View Figures

View References

1	Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC and Alberts SR: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 22:23–30. 2004. View Article : Google Scholar : PubMed/NCBI
2	Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, Mukoyama S, Yasuda S, Tajima T, Makuuchi H and Murayama C: Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology. 50:1362–1366. 2003.PubMed/NCBI
3	Kim DI, Lee TK, Lim IS, Kim H, Lee YC and Kim CH: Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: Isolation of flavonoids of apigenin and luteolin as acting compounds. Toxicol Appl Pharmacol. 205:213–224. 2005. View Article : Google Scholar : PubMed/NCBI
4	Dai ZJ, Wang XJ, Li ZF, Ji ZZ, Ren HT, Tang W, Liu XX, Kang HF, Guan HT and Song LQ: Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3. World J Gastroenterol. 14:7321–7328. 2008. View Article : Google Scholar : PubMed/NCBI
5	Hong H and Liu GQ: Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci. 74:2959–2973. 2004. View Article : Google Scholar : PubMed/NCBI
6	Zhang GH, Wang Q, Chen JJ, Zhang XM, Tam SC and Zheng YT: The anti-HIV-1 effect of scutellarin. Biochem Biophys Res Commun. 334:812–816. 2005. View Article : Google Scholar : PubMed/NCBI
7	Pan Z, Zhao W, Zhang X, Wang B, Wang J, Sun X, Liu X, Feng S, Yang B and Lu Y: Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2. Br J Pharmacol. 162:688–700. 2011. View Article : Google Scholar : PubMed/NCBI
8	Li H, Huang D, Gao Z, Lv Y, Zhang L, Cui H and Zheng J: Scutellarin inhibits cell migration by regulating production of αvβ6 integrin and E-cadherin in human tongue cancer cells. Oncol Rep. 24:1153–1160. 2010.PubMed/NCBI
9	Chan JY, Tan BK and Lee SC: Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation. Anticancer Res. 29:3043–3047. 2009.PubMed/NCBI
10	Korsmeyer SJ: BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59 Suppl 7:1693S–1700S. 1999.PubMed/NCBI
11	Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799–1805. 1994.PubMed/NCBI
12	Harris SL and Levine AJ: The p53 pathway: Positive and negative feedback loops. Oncogene. 24:2899–2908. 2005. View Article : Google Scholar : PubMed/NCBI
13	Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M and Krammer PH: p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med. 188:2033–2045. 1998. View Article : Google Scholar : PubMed/NCBI
14	Boyle P and Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol. 16:481–488. 2005. View Article : Google Scholar : PubMed/NCBI
15	Schrag D, Cramer LD, Bach PB and Begg CB: Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 93:850–857. 2001. View Article : Google Scholar : PubMed/NCBI
16	Feng Y, Zhang S, Tu J, Cao Z, Pan Y, Shang B, Liu R, Bao M, Guo P and Zhou Q: Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells. Leuk Lymphoma. 53:2456–2464. 2012. View Article : Google Scholar : PubMed/NCBI
17	Li H, Fan H, Wang Z, Zheng J and Cao W: Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound. PLoS One. 8:e594732013. View Article : Google Scholar : PubMed/NCBI
18	Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM and Perez-Soler R: Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin Cancer Res. 9:1145–1154. 2003.PubMed/NCBI
19	Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD and Berger SL: Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell. 8:1243–1254. 2001. View Article : Google Scholar : PubMed/NCBI
20	Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP and Korsmeyer SJ: Bcl-2 gene family and the regulation of programmed cell death. Cold Spring Harb Symp Quant Biol. 59:387–393. 1994. View Article : Google Scholar : PubMed/NCBI
21	Swanton E, Savory P, Cosulich S, Clarke P and Woodman P: Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene. 18:1781–1787. 1999. View Article : Google Scholar : PubMed/NCBI
22	Drygin D, O'Brien SE, Hannan RD, McArthur GA and Von Hoff DD: Targeting the nucleolus for cancer-specific activation of p53. Drug Discov Today. 19:259–265. 2014. View Article : Google Scholar : PubMed/NCBI